A citation-based method for searching scientific literature


List of co-cited articles
300 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
71

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. JAMA 2003
71

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
51

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.
M Hanefeld, M Cagatay, T Petrowitsch, D Neuser, D Petzinna, M Rupp. Eur Heart J 2004
455
42

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
40


Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
28

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
28

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.
Thomas A Buchanan, Anny H Xiang, Ruth K Peters, Siri L Kjos, Aura Marroquin, Jose Goico, Cesar Ochoa, Sylvia Tan, Kathleen Berkowitz, Howard N Hodis,[...]. Diabetes 2002
929
26



Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
Markolf Hanefeld, Jean Louis Chiasson, Carsta Koehler, Elena Henkel, Frank Schaper, Theodora Temelkova-Kurktschiev. Stroke 2004
200
22





10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
15



No evidence for a reduction of myocardial infarctions by acarbose.
Floris A van de Laar, Peter L B J Lucassen. Eur Heart J 2004
19
31


Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella. Circulation 2004
323
13


Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray,[...]. Lancet 2005
13


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
13

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
13

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
G S Meneilly, E A Ryan, J Radziuk, D C Lau, J F Yale, J Morais, J L Chiasson, R Rabasa-Lhoret, P Maheux, D Tessier,[...]. Diabetes Care 2000
87
11

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
Floris A van de Laar, Peter L Lucassen, Reinier P Akkermans, Eloy H van de Lisdonk, Guy E Rutten, Chris van Weel. Diabetes Care 2005
345
11

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.
G Sartor, B Scherstén, S Carlström, A Melander, A Nordén, G Persson. Diabetes 1980
255
11



Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
11



The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
J L Chiasson, R G Josse, L A Leiter, M Mihic, D M Nathan, C Palmason, R M Cohen, T M Wolever. Diabetes Care 1996
122
8



Prevention or delay of type 2 diabetes.
Robert S Sherwin, Robert M Anderson, John B Buse, Marshall H Chin, David Eddy, Judith Fradkin, Theodore G Ganiats, Henry N Ginsberg, Richard Kahn, Robin Nwankwo,[...]. Diabetes Care 2004
96
8

Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.
H Delgado, T Lehmann, E Bobbioni-Harsch, J Ybarra, A Golay. Diabetes Metab 2002
43
9


Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais. N Engl J Med 2000
8




Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, Hilary King. Diabetes Care 2004
8

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
8


Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Robert Ratner, Ronald Goldberg, Steven Haffner, Santica Marcovina, Trevor Orchard, Sarah Fowler, Marinella Temprosa. Diabetes Care 2005
368
8

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
William H Herman, Thomas J Hoerger, Michael Brandle, Katherine Hicks, Stephen Sorensen, Ping Zhang, Richard F Hamman, Ronald T Ackermann, Michael M Engelgau, Robert E Ratner. Ann Intern Med 2005
448
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.